Related Experiment Videos
Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis
Insights
Congestive heart failure (CHF) is rising, with many deaths caused by ventricular arrhythmias. While treatments are being studied, current findings suggest antiarrhythmic therapy may not improve long-term survival in CHF patients.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Research
Background:
- Coronary artery and cerebrovascular disease deaths are declining in the U.S.
- Congestive heart failure (CHF) prevalence is increasing.
- Over half of CHF-related deaths are sudden, likely due to ventricular arrhythmias.
Purpose of the Study:
- To review the pathophysiology of arrhythmias in patients with CHF.
- To assess the prevalence of ventricular arrhythmias in CHF.
- To discuss the potential influence of ventricular arrhythmias on CHF prognosis and the impact of antiarrhythmic therapy on survival.
Main Methods:
- Review of existing literature on CHF, ventricular arrhythmias, and treatment outcomes.
- Analysis of prevalence data for ventricular arrhythmias (couplets, nonsustained ventricular tachycardia) in CHF patients.
- Discussion of potential contributing factors to arrhythmias, including left ventricular abnormalities and electrolyte imbalances.
Main Results:
- Ventricular arrhythmias, including couplets and nonsustained ventricular tachycardia, are highly prevalent in CHF patients (87% and 54% respectively in reviewed studies).
- Factors like left ventricular mechanical abnormalities, hypokalemia, hypomagnesemia, and inotropic therapy may contribute to arrhythmias in CHF.
- Emerging data suggest ventricular arrhythmias might independently affect prognosis in CHF patients.
Conclusions:
- Ventricular arrhythmias are common in patients with congestive heart failure.
- The role of antiarrhythmic therapy in improving long-term survival for CHF patients with ventricular arrhythmias requires further investigation.
- Preliminary data indicate that current antiarrhythmic treatments may not significantly impact long-term survival in this population.
Abstract:
While the number of deaths from coronary artery and cerebrovascular disease is clearly decreasing in the U.S., the prevalence of congestive heart failure (CHF) seems to be increasing. Many studies have found that more than half of the CHF-related deaths are sudden, and presumably are due to ventricular arrhythmias. Knowledge of the pathophysiology of arrhythmias in the patient with CHF is limited, but left ventricular mechanical abnormalities, diuretic-induced hypokalemia, hypomagnesemia and inotropic therapy may play a role. The prevalence of couplets, multiformed ventricular premature complexes or both is very high, averaging 87% in 8 different studies. The prevalence of nonsustained ventricular tachycardia, determined by ambulatory electrocardiographic recordings, is also quite high; it is approximately 54% in these same studies. Although still unclear, some data now suggest that ventricular arrhythmias may independently influence prognosis in patients with CHF. Future research is obviously necessary to evaluate the influence of antiarrhythmic therapy on survival. However, preliminary findings appear to indicate that treatment may not affect long-term survival in these patients.